ScoreWhy is Sichuan Hebang Biotechnology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 12.99%
- The company has been able to generate a Return on Capital Employed (avg) of 12.99% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 3.06% and Operating profit at -180.32% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 9.56% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 3.06% and Operating profit at -180.32% over the last 5 years
4
Flat results in Jun 26
- INTEREST(9M) At CNY 95.64 MM has Grown at 50.47%
- NET PROFIT(9M) At CNY -189.11 MM has Grown at -36.95%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.17 times
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 15.08%, its profits have fallen by -439.8%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sichuan Hebang Biotechnology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sichuan Hebang Biotechnology Co., Ltd.
16.92%
0.44
50.84%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.06%
EBIT Growth (5y)
-180.32%
EBIT to Interest (avg)
31.58
Debt to EBITDA (avg)
1.41
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
0.33
Tax Ratio
22.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.69%
ROE (avg)
9.56%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.13
EV to EBIT
-83.72
EV to EBITDA
45.13
EV to Capital Employed
1.11
EV to Sales
3.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.33%
ROE (Latest)
-2.69%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,130.35 MM
RAW MATERIAL COST(Y)
Fallen by -476.3% (YoY
CASH AND EQV(HY)
Highest at CNY 14,060.76 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 8.18 %
OPERATING PROFIT(Q)
Highest at CNY 498.38 MM
PRE-TAX PROFIT(Q)
Highest at CNY 245.61 MM
NET PROFIT(Q)
Highest at CNY 206.57 MM
EPS(Q)
Highest at CNY 0.03
-19What is not working for the Company
INTEREST(9M)
At CNY 95.64 MM has Grown at 50.47%
NET PROFIT(9M)
At CNY -189.11 MM has Grown at -36.95%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.17 times
NET SALES(Q)
At CNY 1,500.29 MM has Fallen at -12.08%
Here's what is working for Sichuan Hebang Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY 245.61 MM has Grown at 357.3%
over average net sales of the previous four periods of CNY -95.46 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 206.57 MM has Grown at 362.24%
over average net sales of the previous four periods of CNY -78.77 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 1,130.35 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Operating Profit
Highest at CNY 498.38 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 245.61 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 206.57 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.03
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 14,060.76 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 8.18 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -476.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sichuan Hebang Biotechnology Co., Ltd.
Interest
At CNY 95.64 MM has Grown at 50.47%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 1,500.29 MM has Fallen at -12.08%
over average net sales of the previous four periods of CNY 1,706.47 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 1.17 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
